Importance of Non-Cardiovascular Comorbidities in Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction

Non-cardiovascular comorbidities such as anaemia, diabetes mellitus and kidney or pulmonary disease in addition to advanced age were independent predictors of adverse outcomes in patients with AF and HFpEF. Our study suggests the importance of focusing on these non-cardiovascular comorbidities for individualized risk stratification and optimal management in patients with AF and HFpEF.

Authors

Institutions

Publication Details

Journal
ESC Heart Failure
Published
2024-09-21
DOI
https://doi.org/10.1002/ehf2.15093
Citations
5
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
2.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Importance of Non-Cardiovascular Comorbidities in Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction

Neiko Ozasa, Koh Ono, Yasutaka Inuzuka, Yodo Tamaki et al.
5 citations
ESC Heart Failure
Atrial Fibrillation Management and Outcomes
2.01
article

Importance of Non-Cardiovascular Comorbidities in Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction

Neiko Ozasa, Koh Ono, Yasutaka Inuzuka, Yodo Tamaki, Masaharu Akao, Yasuhiro Hamatani, Hiromichi Wada, Mitsuru Abe, Tetsuma Kawaji, Masahiro Esato, Moritake Iguchi, Koji Hasegawa, Takeshi Kimura, Takao Kato, Hikari Tsuji
article en
5 citations

Abstract

Non-cardiovascular comorbidities such as anaemia, diabetes mellitus and kidney or pulmonary disease in addition to advanced age were independent predictors of adverse outcomes in patients with AF and HFpEF. Our study suggests the importance of focusing on these non-cardiovascular comorbidities for individualized risk stratification and optimal management in patients with AF and HFpEF.

ESC Heart FailureVol. 12(1)
Kyoto University (JP), Tenri Hospital (JP), Kyoto Medical Center (JP), Fukuoka Tokushukai Hospital (JP), Shiga Medical Center for Adults (JP), Ogaki Municipal Hospital (JP), Uji Hospital (JP), Takano Hospital (JP), Mitsubishi Kyoto Hospital (JP), Municipal Hirakata City Hospital (JP)
Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, AstraZeneca, Sanofi, Takeda Pharmaceutical Company, Japan Agency for Medical Research and Development, Bayer HealthCare, Astellas Pharma, Novartis Pharma, Merck Sharp and Dohme, Daiichi Sankyo Company, Daiichi Sankyo Europe
Good health and well-being
Openalex Percentile: Top 12%
Atrial Fibrillation Management and Outcomes
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.